机译:用效率治疗抗体中和SARS-COV-2和SARS-COV的结构基础
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing 100101 Peoples R China|Univ Chinese Acad Sci Beijing 100049 Peoples R China;
Acad Mil Med Sci Inst Microbiol & Epidemiol State Key Lab Pathogen & Biosecur Beijing Peoples R China;
Acad Mil Med Sci Inst Microbiol & Epidemiol State Key Lab Pathogen & Biosecur Beijing Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing 100101 Peoples R China;
Sinocelltech Ltd Beijing Prot & Antibody RandD Engn Ctr Beijing 100176 Peoples R China;
Natl Inst Food & Drug Control NIFDC Inst Lab Anim Resources Div Anim Model Res Beijing 102629 Peoples R China;
Natl Inst Food & Drug Control NIFDC Inst Biol Prod Control Div HIV AIDS & Sex Transmitted Virus Vaccines Beijing 102629 Peoples R China;
Acad Mil Med Sci Inst Microbiol & Epidemiol State Key Lab Pathogen & Biosecur Beijing Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing 100101 Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing 100101 Peoples R China;
Acad Mil Med Sci Inst Microbiol & Epidemiol State Key Lab Pathogen & Biosecur Beijing Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing 100101 Peoples R China|Univ Chinese Acad Sci Beijing 100049 Peoples R China;
Natl Inst Food & Drug Control NIFDC Inst Biol Prod Control Div HIV AIDS & Sex Transmitted Virus Vaccines Beijing 102629 Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing 100101 Peoples R China|Univ Chinese Acad Sci Beijing 100049 Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing 100101 Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing 100101 Peoples R China;
Acad Mil Med Sci Inst Microbiol & Epidemiol State Key Lab Pathogen & Biosecur Beijing Peoples R China;
Natl Inst Food & Drug Control NIFDC Inst Biol Prod Control Div HIV AIDS & Sex Transmitted Virus Vaccines Beijing 102629 Peoples R China;
Sinocelltech Ltd Beijing Prot & Antibody RandD Engn Ctr Beijing 100176 Peoples R China|Sino Biol Inc BDA Beijing Antibody Res Key Lab Bldg 9 Jing Dong Bei Technol Pk Beijing 100176 Peoples R China|Chinese Acad Med Sci & Peking Union Med Coll Cell Culture Engn Ctr Beijing 100005 Peoples R China;
Natl Inst Food & Drug Control NIFDC Inst Biol Prod Control Div HIV AIDS & Sex Transmitted Virus Vaccines Beijing 102629 Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing 100101 Peoples R China;
Acad Mil Med Sci Inst Microbiol & Epidemiol State Key Lab Pathogen & Biosecur Beijing Peoples R China;
Chinese Acad Sci Inst Biophys CAS Key Lab Infect & Immun Natl Lab Macromol Beijing 100101 Peoples R China|Univ Chinese Acad Sci Beijing 100049 Peoples R China;
机译:SARS-COV-2有效中和的结构基础及抗体亲和力成熟的作用
机译:两种有效治疗抗体中和日本脑炎病毒的结构基础
机译:具有普遍的VH1-2衍生抗体类的强化SARS-COV-2中和的模块化基础
机译:融合构象中的结构限制型流感亚种疫苗,可能产生中性抗体反应
机译:通过广泛中和抗体抑制流感病毒的结构基础。
机译:用效率治疗抗体中和SARS-COV-2和SARS-COV的结构基础
机译:Emerging B.1.351和B.1.1.7变体的结构依据由两个有效的SARS-COV-2中和抗体